These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 33238464)

  • 1. Drug Repurposing Approaches to Combating Viral Infections.
    Trivedi J; Mohan M; Byrareddy SN
    J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33238464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Old Drugs for a New Virus: Repurposed Approaches for Combating COVID-19.
    Saul S; Einav S
    ACS Infect Dis; 2020 Sep; 6(9):2304-2318. PubMed ID: 32687696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug Discovery Strategies for SARS-CoV-2.
    Shyr ZA; Gorshkov K; Chen CZ; Zheng W
    J Pharmacol Exp Ther; 2020 Oct; 375(1):127-138. PubMed ID: 32723801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of Potent SARS-CoV-2 Inhibitors from Approved Antiviral Drugs via Docking and Virtual Screening.
    Chtita S; Belhassan A; Aouidate A; Belaidi S; Bouachrine M; Lakhlifi T
    Comb Chem High Throughput Screen; 2021; 24(3):441-454. PubMed ID: 32748740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario.
    Gudadappanavar AM; Benni J
    J Basic Clin Physiol Pharmacol; 2020 Sep; 31(6):. PubMed ID: 32924964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 RNA Dependent RNA polymerase (RdRp) - A drug repurposing study.
    Ahmad J; Ikram S; Ahmad F; Rehman IU; Mushtaq M
    Heliyon; 2020 Jul; 6(7):e04502. PubMed ID: 32754651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Binding Mechanism and Pharmacology Comparative Analysis of Noscapine for Repurposing against SARS-CoV-2 Protease.
    Kumar N; Sood D; van der Spek PJ; Sharma HS; Chandra R
    J Proteome Res; 2020 Nov; 19(11):4678-4689. PubMed ID: 32786685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposing old drugs as antiviral agents for coronaviruses.
    Yang CW; Peng TT; Hsu HY; Lee YZ; Wu SH; Lin WH; Ke YY; Hsu TA; Yeh TK; Huang WZ; Lin JH; Sytwu HK; Chen CT; Lee SJ
    Biomed J; 2020 Aug; 43(4):368-374. PubMed ID: 32563698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repurposing antiviral drugs on recently emerged viral infections: A review article.
    Swathi K; Nikitha B; Chandrakala B; Lakshmanadevi K; Malleswari M
    Mater Today Proc; 2021 Mar; ():. PubMed ID: 33816131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review.
    Santos J; Brierley S; Gandhi MJ; Cohen MA; Moschella PC; Declan ABL
    Viruses; 2020 Jun; 12(7):. PubMed ID: 32629804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repurposing drugs against the main protease of SARS-CoV-2: mechanism-based insights supported by available laboratory and clinical data.
    Chakraborti S; Bheemireddy S; Srinivasan N
    Mol Omics; 2020 Oct; 16(5):474-491. PubMed ID: 32696772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial intelligence approach fighting COVID-19 with repurposing drugs.
    Ke YY; Peng TT; Yeh TK; Huang WZ; Chang SE; Wu SH; Hung HC; Hsu TA; Lee SJ; Song JS; Lin WH; Chiang TJ; Lin JH; Sytwu HK; Chen CT
    Biomed J; 2020 Aug; 43(4):355-362. PubMed ID: 32426387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-SARS-CoV-2 Potential of Artemisinins In Vitro.
    Cao R; Hu H; Li Y; Wang X; Xu M; Liu J; Zhang H; Yan Y; Zhao L; Li W; Zhang T; Xiao D; Guo X; Li Y; Yang J; Hu Z; Wang M; Zhong W
    ACS Infect Dis; 2020 Sep; 6(9):2524-2531. PubMed ID: 32786284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapamycin as a potential repurpose drug candidate for the treatment of COVID-19.
    Husain A; Byrareddy SN
    Chem Biol Interact; 2020 Nov; 331():109282. PubMed ID: 33031791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
    Froggatt HM; Heaton BE; Heaton NS
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Drug-Repurposing-Driven Advances in the Discovery of Novel Antibiotics.
    Konreddy AK; Rani GU; Lee K; Choi Y
    Curr Med Chem; 2019; 26(28):5363-5388. PubMed ID: 29984648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weapons and Strategies against COVID-19: A Perspective.
    Mishra R; Chaudhary K; Mishra I
    Curr Pharm Biotechnol; 2023 May; ():. PubMed ID: 37231727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 therapeutics: Clinical application of repurposed drugs and futuristic strategies for target-based drug discovery.
    Kumar S; Basu M; Ghosh P; Pal U; Ghosh MK
    Genes Dis; 2023 Jul; 10(4):1402-1428. PubMed ID: 37334160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspects of Antiviral Strategies Based on Different Phototherapy Approaches: Hit by the Light.
    Kunstek H; Vreken F; Keita A; Hamblin MR; Dumarçay F; Varbanov M
    Pharmaceuticals (Basel); 2022 Jul; 15(7):. PubMed ID: 35890156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant perspectives on various viral infections targeted antiviral drugs and vaccines including COVID-19 pandemicity.
    Arumugam GS; Damodharan K; Doble M; Thennarasu S
    Mol Biomed; 2022 Jul; 3(1):21. PubMed ID: 35838929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.